Researchers are looking at changes in gut bacteria that stimulate the immune system in dogs with inflammatory bowel disease to help identify novel ways to diagnose and treat this disease.

Researchers will determine if a promising new drug used to treat dogs with hemangiosarcoma would benefit dogs with other incurable cancers.

Researchers will find out how the specific enzymes in dogs break down common environmental chemicals that have been linked to cancers in humans.

Researchers will study the potential of a novel type of stem cell to treat inflammatory and immune-mediated diseases in dogs.

Researchers will evaluate the effects of additive solutions to improve blood platelet efficacy and storage for life-saving transfusion in dogs.

Researchers will evaluate an advanced imaging technique to improve the diagnosis and monitoring of spinal cord lesions associated with canine degenerative myelopathy, a spinal cord disease in dogs.

Researchers will explore metabolic drivers of cancer growth and look for new therapy targets for osteosarcoma, the most common type of bone cancer in dogs.

Researchers will determine if common heart medications are an effective adjunct therapy for dogs with hemangiosarcoma.

Researchers will identify potential treatment targets for B-cell chronic lymphocytic leukemia in dogs and ways to identify high-risk patients.

Researchers will develop an assay to measure canine thrombopoietin (TPO), a bone marrow growth factor, to improve the diagnosis and treatment of bleeding disorders in dogs with immune platelet defects.